JPX · 219A.T
Heartseed, Inc.
¥3,015-¥75 (-2.43%)
Heartseed, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.07% below the high.
Loading market information…
JPX · 4894.T · JPY
Stock price, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Cuorips Inc.’s quoted price sits in the lower half of its reported 52-week range, 43.06% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Cuorips Inc.’s next earnings report is currently expected on Nov 13, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Cuorips Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥3,015-¥75 (-2.43%)
Heartseed, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.07% below the high.
¥273-¥5 (-1.8%)
Healios K.K.’s quoted price sits in the lower half of its reported 52-week range, 45.29% below the high.
¥629-¥138 (-17.99%)
Japan Tissue Engineering Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.15% below the high.
¥498+¥2 (+0.4%)
Innovacell Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.1% below the high.
¥122-¥4 (-3.17%)
ReproCELL Incorporated’s quoted price sits in the lower half of its reported 52-week range, 40.2% below the high.
¥188-¥7 (-3.59%)
CellSeed Inc.’s quoted price sits in the lower half of its reported 52-week range, 57.66% below the high.
¥403-¥16 (-3.82%)
J-Pharma Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.19% below the high.
¥701-¥6 (-0.85%)
StemCell Institute Inc.’s quoted price sits in the lower half of its reported 52-week range, 28.18% below the high.
